Clinical trial

Efficacy, Effect on Gametocytes and Tolerability of the Addition of Artesunate…

NCT00378625 · Centro Internacional de Entrenamiento e Investigaciones Médicas, Other · Completed

Key facts

NCT number NCT00378625
Title Efficacy, Effect on Gametocytes and Tolerability of the Addition of Artesunate to Amodiaquine in Colombia
Official title Randomised, Double Blind Clinical Trial of the Efficacy, Effect on Gametocytes and Tolerability of Amodiaquine Vs Amodiaquine Plus Artesunate in the Treatment of Uncomplicated P. Falciparum Malaria in Quibdo, Colombia
Lead sponsor Centro Internacional de Entrenamiento e Investigaciones Médicas, Other
Collaborators World Health Organization Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS)
Status Completed
Phase Phase 3
Study type Interventional
Conditions Malaria, Falciparum, Antimalarials
Intervention type Drug
Interventions Artesunate
Enrollment 360
Start date Apr 1, 2000
Completion Mar 1, 2006
First posted Sep 20, 2006
Last update posted Sep 20, 2006
Countries Colombia

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies